Skip to main content
. 2021 Jan 5;20:497–507. doi: 10.1016/j.omtm.2020.12.014

Figure 4.

Figure 4

i.c.v. delivery of scAAV9.CB.CLN6 prevents neuronal loss in the DLG, V1, and SC

(A–C) A single, postnatal day 1 injection of scAAV9.CB.CLN6 delivered via CSF prevents progressive neuronal loss in the (A) DLG, (B) SC, and (C) V1 until 9 months of age. n = 6/treatment for each time point, represented by equal numbers of males and females. Mean ± SEM, one-way ANOVA for each time point, Bonferroni correction. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001.